Showing 5 of 48 posts
April 25, 2019 | Blogs, Infographics
CBPartners uncovers the most impactful clinical considerations for commercial PDx success in this handy infographic.
March 6, 2019 | Blogs
VC investment in digital healthcare has been growing rapidly (+42% vs. 2017) as the potential of new technology to solve complex issues, ranging from providing healthcare services to managing chronic conditions, evolves. CBPartners takes a look at investment trends in digital health.
February 21, 2019 | Blogs
Vermont’s fledgling drug importation law has undergone preliminary savings analysis, with uninspiring projections of a 3.8% drug cost savings rate. CBPartners evaluates the real impact of this new policy.
January 14, 2019 | Blogs
September 9, 2018 | Blogs
When the engine of innovation gets the green light of marketing authorisation, it is typically first in the USA, and sometimes for the EMA’s (European Medicines Agency) jurisdiction over much of Europe. Unfortunately, China is too often one the last markets among the major and highest-tier of emerging markets to be considered for broad patient access. CBPartners explores the evolving reimbursement dynamics in China.